Tirzepatide, a novel therapeutic agent, has emerged as a beacon of hope for individuals grappling with metabolic dysfunction-associated steatohepatitis (MASH).…
Agenus closed its previously disclosed $141 million strategic collaboration with Zydus Lifesciences, which is designed to accelerate global development and…
In a remarkable advancement in the field of agricultural genetics, a groundbreaking genome-wide association study (GWAS) has unveiled critical insights…